- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03169309
The BEST Study: The Efficacy of Brain Entrainment Sleep Technology in Military Healthcare Beneficiaries (BEST)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study will follow a prospective, one group pre- and post-intervention design.
A sample of 162 military healthcare beneficiaries (within the Kaiserslautern Military Community footprint) with complaints of poor sleep quality will be instructed to wear sleep actigraphy monitors and complete daily sleep diaries upon waking for a total of four weeks. On weeks 3 and 4, participants will use BET at bedtime for a minimum of 30 minutes. Pre and post sleep quality measures will be compared along with pre- and post- c-reactive protein (CRP) measures and a post-study questionnaire to assess participants' perception about the technology.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Landstuhl, Germany
- Landstuhl Regional Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Score greater than or equal to 15 on the Insomnia Severity Index (ISI)
- Affiliated with at least one of the 13 installations within the Kaiserslautern Military Community (KMC) area
- Eligible to receive healthcare at Landstuhl Regional Medical Center (LRMC)
- Are 18 years or older
- Can read and speak English
- Are able to commit to a 4 week study
Exclusion Criteria:
- Are taking any type of medication that causes drowsiness
- Have been diagnosed with moderate to severe traumatic brain injury (TBI)
- Have a history of epilepsy
- Are taking any medication in the anti-seizure category
- Have been diagnosed with, taking medication for, or are currently being evaluated for a psychological health issue as defined by the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) that will prohibit them from using intervention as perscribed.
- Have ear trauma, difficulty hearing or wear a hearing aide
- Have a chronic inflammatory health issue
Are pregnant or are trying to become pregnant in the next 4 weeks
*Women of child bearing age will be asked to provide a urine sample for a pregnancy test
- Are currently using BET
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Pre and Post Intervention
One Study Arm - Quantitative and qualitative sleep quality measure will be captured at baseline (Phase I/Week 1-2), while using Brain Entrainment Technology (Phase II/Week3-4), and after using the technology.
|
Brain Entrainment Technology (BET), also known as Binaural Beat Technology (BBT), is a sound technology where two slightly different tones are present to each ear and the brain produces a third tone.
This third tone impacts the reticular activating system which alters the action potentials of the thalamus and cerebral cortex in turn changing the brain wave frequency to alter the state of consciousness of the listener.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
"Quantitative" Sleep Quality (via Sleep Actigraphy Watch)
Time Frame: Daily over the course of 4 weeks
|
Sleep actigraphy monitor will measure wake/sleep.
Using special software, that information is then articulated into graphical and tabulated report that shows the movement that occurred throughout the wake and sleep cycles as well as light exposure that may have affected sleep.
The report gives the a) time the participants went to bed, b) time they woke up, c) number of hours they were in the bed, d) total number of hours asleep, e) number of minutes it took to fall asleep, f) percent efficiency of their sleep, g) number of minutes awaken after sleep onset, and h) total number of times they woke up after falling asleep.
|
Daily over the course of 4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Insomnia Severity Level (via Insomnia Severity Index Questionnaire)
Time Frame: Baseline
|
A 7-item questionnaire will be used as a screening tool to quantify the severity level of the participant's poor sleep quality.
It is comprised of a 5-point Likert scale with a total score from 0-28 with 15 or greater indicating moderate to severe insomnia
|
Baseline
|
"Qualitative" Sleep Quality (via Sleep Foundation Sleep Diary Questionnaire)
Time Frame: Daily over the course of 4 weeks
|
A 14-item questionnaire will be used to capture sleep habits.
Questions cover: napping, caffeine, alcohol, exercise, medication, meals, sleepiness, sleep hygiene, and quality.
This instrument is not scored but merely used to assess patterns and if those patterns changed over the course of the study.
|
Daily over the course of 4 weeks
|
Overall Impression of Sleep Quality (via Pittsburgh Sleep Quality Index Questionnaire)
Time Frame: Baseline and Week 4 (after using intervention)
|
A 24-item item questionnaire gives an accumulative score based on sub scores of sleep duration, sleep disturbance, sleep latency, number of days of dysfunction due to sleepiness, sleep efficiency, sleep quality, and medication usage.
Minimum Score = 0 (better); Maximum Score = 21 (worse).
Interpretation: TOTAL < 5 associated with good sleep quality and TOTAL > 5 associated with poor sleep,
|
Baseline and Week 4 (after using intervention)
|
Inflammatory Biomarker (via C-Reactive Protein Lab)
Time Frame: Baseline and Week 4 (after using intervention)
|
A blood sample for c-reactive protein will measures the inflammatory process.
After accounting for any external influences on CRP level, this measure will be correlated with the objective and subjective sleep data to assess if changes in sleep quality affected the inflammatory response.
|
Baseline and Week 4 (after using intervention)
|
Extenuating Factor Affecting C-Reactive Protein Level (via C-Reactive Protein Questionnaire)
Time Frame: Baseline and Week 4 (after using intervention)
|
Since exposure to stress, infection, allergy, injury, or menstruation could affect CRP levels; this 6-item questionnaire will be used to note other possible co-variates that could have impacted CRP levels.
|
Baseline and Week 4 (after using intervention)
|
Overall Impression of Brain Entrainment Technology (via Post Study Questionnaire)
Time Frame: Week 4 (after using intervention)
|
A 10-item questionnaire will be used at the completion of the study to instrument will capture any subjective comments from the participants as to assess the participant's perception about the technology as well as to assess ways that will help improve future studies using the same equipment and/or technology.
|
Week 4 (after using intervention)
|
Collaborators and Investigators
Investigators
- Principal Investigator: MeLisa Gantt, PhD, Gantt Clinical Institute LLC
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- M-10544
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sleep Disorders, Intrinsic
-
Merck Sharp & Dohme LLCCompletedMental Disorders | Dyssomnias | Sleep Initiation and Maintenance Disorders | Sleep Disorders | Sleep Disorder, Intrinsic
-
Merck Sharp & Dohme LLCCompletedDyssomnias | Sleep Disorders | Mental Disorder | Sleep Initiation and Maintenance Disorder; Elderly | Sleep Disorder, Intrinsic
-
SleepUp Tecnologia em Saúde LtdaActive, not recruiting
-
Boehringer IngelheimCompletedSleep Initiation and Maintenance Disorders
-
St. Olavs HospitalNorwegian University of Science and TechnologyCompleted
-
Columbia UniversityCompleted
-
Koko Home, Inc.Stanford UniversityRecruitingSleep Disorder | Insomnia | Sleep Initiation and Maintenance Disorders | Sleep | Sleep Disturbance | Sleep HygieneUnited States
-
DreemCompletedSleep Initiation and Maintenance Disorders | Sleep | Sleep Disturbance | Insomnia, SecondaryUnited States
-
Eunice Kennedy Shriver National Institute of Child...Sanofi-SynthelaboCompletedSleep Disorder | InsomniaUnited States
-
Neurovalens Ltd.The Hong Kong Polytechnic University; University of UlsterCompletedInsomnia | Sleep DisturbanceHong Kong, United Kingdom
Clinical Trials on Brain Entrainment Technology
-
University of ManchesterUniversity of LeedsCompleted
-
Children's Hospital Medical Center, CincinnatiEunice Kennedy Shriver National Institute of Child Health and Human Development...RecruitingAutism Spectrum Disorder | Autistic Disorder | Fragile X Syndrome | Asperger SyndromeUnited States
-
ElMindA LtdUnknownHealthy | Cognitive Impairment | Neurological DisorderUnited States
-
Albert Einstein Healthcare NetworkNational Institute on Deafness and Other Communication Disorders (NIDCD)Recruiting
-
Medical University of South CarolinaNational Institute on Deafness and Other Communication Disorders (NIDCD)Recruiting
-
Helen LockeUniversity of LeedsNot yet recruiting
-
Beijing Tiantan HospitalShanghai Joyingmed Sensory Stimulation LabNot yet recruitingCognitive Dysfunction | Subarachnoid Hemorrhage, Aneurysmal
-
Icahn School of Medicine at Mount SinaiRecruitingPrematurityUnited States
-
Icahn School of Medicine at Mount SinaiEnrolling by invitation
-
University of South CarolinaUnknown